Relevant publications

Cypers, W, Kiser, J & Marr, A.P. (2013) The XEVMPD, one year on – An industry viewpoint
Regulatory Rapporteur, 10 (10), 12-15

Marr, A.P. (2012) Impact of the reduced requirements for the Eudravigilance medicinal product dictionary
Scrip Regulatory Affairs, Apr 2012, 15-17

Marr, A.P. (2011) EMA sheds new light on requirements for the Eudravigilance medicinal product dictionary
Scrip Regulatory Affairs, Oct 2011, 11-14

Marr, A.P. (2011) EMA mandates Eudravigilance medicinal product dictionary for all authorised products in Europe
Scrip Regulatory Affairs, Aug 2011, 14-17

Marr, A.P. (2010) ICH progresses new standards for the Individual Case Safety Report and unambiguous identification of medicinal products
Pharmacovigilance Review, 4 (3), 7-9

Marr, A.P. (2010) The European e-submission experience : An applicant’s view of different procedures
Regulatory Focus, 15 (6), 8-13

Marr, A.P.; Page, K.J. & Williams, G.K. (2010) A Future for NeeS
Regulatory Affairs Journal, 21 (4), 211

Holmes, C; Marr, A.P.; Menges, K; Kaindl, T.; Franken, A.; Gould, M. & Gibbard, M (2010) PIM – the EU’s planned default process for product information submission and management
Regulatory Rapporteur, 7 (1), 4-7

Page, K.J.; Marr, A.P. & Williams, G.K. (2010) Is Europe ready for eCTD? An industry perspective
Regulatory Rapporteur, 7 (1), 8- 11

Buxton, T & Marr, A.P. (2005) PIM – a new method for the submission of product information in the Centralised Procedure
Regulatory Rapporteur, 2 (4), 12-15

Marr, A.P. (2002) The specification for the electronic Common Technical Document (eCTD) – your chance to comment
ESRA Rapporteur, 9 (4), 4-7

Marr, A.P. (2002) Letter to the Editor
The Regulatory Review, 5 (7), 31

Marr, A.P. (2001) The electronic Common Technical Document – Why is it needed and what is it likely to contain?
Regulatory Affairs Focus, 11 (3), 11-15

Marr, A.P. (2001) The impact of ICH M2 and the eCTD: Current status and future directions
In : Fulfilling the potential of electronic interactions between the pharmaceutical industry and regulatory authorities : Issues and initiatives, Publ. CMR International, pp 7-13